BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30063429)

  • 1. Sporadic pituitary adenomas: the role of germline mutations and recommendations for genetic screening.
    Iacovazzo D; Hernández-Ramírez LC; Korbonits M
    Expert Rev Endocrinol Metab; 2017 Mar; 12(2):143-153. PubMed ID: 30063429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study.
    Iacovazzo D; Caswell R; Bunce B; Jose S; Yuan B; Hernández-Ramírez LC; Kapur S; Caimari F; Evanson J; Ferraù F; Dang MN; Gabrovska P; Larkin SJ; Ansorge O; Rodd C; Vance ML; Ramírez-Renteria C; Mercado M; Goldstone AP; Buchfelder M; Burren CP; Gurlek A; Dutta P; Choong CS; Cheetham T; Trivellin G; Stratakis CA; Lopes MB; Grossman AB; Trouillas J; Lupski JR; Ellard S; Sampson JR; Roncaroli F; Korbonits M
    Acta Neuropathol Commun; 2016 Jun; 4(1):56. PubMed ID: 27245663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of Acromegaly and Gigantism.
    Bogusławska A; Korbonits M
    J Clin Med; 2021 Mar; 10(7):. PubMed ID: 33805450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical, pathological, and genetic features of familial isolated pituitary adenomas.
    Beckers A; Daly AF
    Eur J Endocrinol; 2007 Oct; 157(4):371-82. PubMed ID: 17893250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: The roles of AIP and GPR101 in familial isolated pituitary adenomas (FIPA).
    Vasilev V; Daly AF; Trivellin G; Stratakis CA; Zacharieva S; Beckers A
    Endocr Relat Cancer; 2020 Aug; 27(8):T77-T86. PubMed ID: 32083999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Molecular Update on Genetic Causes of Pituitary Adenomas.
    Vasilev V; Daly AF; Zacharieva S; Beckers A
    Horm Metab Res; 2020 Aug; 52(8):553-561. PubMed ID: 32299111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gigantism: X-linked acrogigantism and GPR101 mutations.
    Iacovazzo D; Korbonits M
    Growth Horm IGF Res; 2016; 30-31():64-69. PubMed ID: 27743704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
    Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very low frequency of germline GPR101 genetic variation and no biallelic defects with AIP in a large cohort of patients with sporadic pituitary adenomas.
    Lecoq AL; Bouligand J; Hage M; Cazabat L; Salenave S; Linglart A; Young J; Guiochon-Mantel A; Chanson P; Kamenický P
    Eur J Endocrinol; 2016 Apr; 174(4):523-30. PubMed ID: 26792934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for genetic causes of growth hormone hypersecretion.
    Rostomyan L; Beckers A
    Growth Horm IGF Res; 2016; 30-31():52-57. PubMed ID: 27756606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Relevance of Genetic Analysis in Patients With Pituitary Adenomas: A Systematic Review.
    van den Broek MFM; van Nesselrooij BPM; Verrijn Stuart AA; van Leeuwaarde RS; Valk GD
    Front Endocrinol (Lausanne); 2019; 10():837. PubMed ID: 31920960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic GPR101 Duplication Causing X-Linked Acrogigantism (XLAG)-Diagnosis and Management.
    Rodd C; Millette M; Iacovazzo D; Stiles CE; Barry S; Evanson J; Albrecht S; Caswell R; Bunce B; Jose S; Trouillas J; Roncaroli F; Sampson J; Ellard S; Korbonits M
    J Clin Endocrinol Metab; 2016 May; 101(5):1927-30. PubMed ID: 26982009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary Disease in
    Bilbao Garay I; Daly AF; Egaña Zunzunegi N; Beckers A
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32604740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Genetic Causes of Pituitary Adenomas.
    Caimari F; Korbonits M
    Clin Cancer Res; 2016 Oct; 22(20):5030-5042. PubMed ID: 27742789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center.
    Daly AF; Cano DA; Venegas-Moreno E; Petrossians P; Dios E; Castermans E; Flores-Martínez A; Bours V; Beckers A; Soto-Moreno A
    Endocr Connect; 2019 Apr; 8(4):338-348. PubMed ID: 30822274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia.
    Occhi G; Trivellin G; Ceccato F; De Lazzari P; Giorgi G; Demattè S; Grimaldi F; Castello R; Davì MV; Arnaldi G; Salviati L; Opocher G; Mantero F; Scaroni C
    Eur J Endocrinol; 2010 Sep; 163(3):369-76. PubMed ID: 20530095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study.
    Ferraù F; Romeo PD; Puglisi S; Ragonese M; Torre ML; Scaroni C; Occhi G; De Menis E; Arnaldi G; Trimarchi F; Cannavò S
    Endocrine; 2016 Dec; 54(3):762-767. PubMed ID: 26815903
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.